secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2026-06-04T20:48:21+00:00
Accession:  0001493152-26-027295
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DNA X terminates $500M equity line with Chardan Capital Markets
---------------------------------------------------------------

- Terminated ChEF Purchase Agreement with Chardan Capital Markets, effective May 28, 2026.
- Original agreement committed Chardan to purchase up to $500M of common stock.
- Registration Rights Agreement also terminated.
- No replacement financing disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226027295/0001493152-26-027295-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226027295/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-027295

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer